President Trump recently reiterated the pledge he made before taking office — that he’d work tirelessly to lower prices of prescription drugs. AdvertisementIf the president were serious about addressing stratospheric drug prices and pharmaceutical-industry greed, he’d be proposing more aggressive measures. But Republican lawmakers, acting at the behest of drug companies, for years have resisted moves to allow Medicare to bargain with pharmaceutical manufacturers. In fact, there’s no limit to what drug companies can charge in this country. Trump’s plan, in other words, is the laziest possible approach to tackling runaway drug prices, offloading our problem onto another country that’s taken more meaningful steps.

Source: Los Angeles Times December 03, 2019 00:47 UTC